Latest Articles
UC Cancer Center members present radiation oncology research at national conference - University of Cincinnati
UC Cancer Center members present radiation oncology research at national conference University of Cincinnati
Published: Sept. 29, 2025, 2:39 p.m.
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer - Oncology Nurse Advisor
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer Oncology Nurse Advisor
Published: Sept. 29, 2025, 4 a.m.
Genmab takes its Profound buy into endometrial | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Genmab takes its Profound buy into endometrial | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: Sept. 16, 2025, 3:39 p.m.
Panel Discussion on Endometrial Cancer Challenges and Advances – FDA Oncology - Oncodaily
Panel Discussion on Endometrial Cancer Challenges and Advances – FDA Oncology Oncodaily
Published: Sept. 14, 2025, 7:31 p.m.
Rx Road Map: Durvalumab for Endometrial Cancer - Oncology Nursing News
Rx Road Map: Durvalumab for Endometrial Cancer Oncology Nursing News
Published: Sept. 11, 2025, 6:21 p.m.
GSK enters Indian oncology market with gynaecological cancer drugs - MSN
GSK enters Indian oncology market with gynaecological cancer drugs MSN
Published: Aug. 28, 2025, 8:16 a.m.
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer - Targeted Oncology
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer Targeted Oncology
Published: Aug. 26, 2025, 6:30 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News
Published: Aug. 26, 2025, 6:04 p.m.
Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation - AInvest
Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation AInvest
Published: Aug. 26, 2025, 1:01 p.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN
Published: Aug. 26, 2025, 12:50 p.m.
Link copied to clipboard!